Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:59 PM EDT
152.59quote price arrow up+2.88 (+1.92%)
Volume
388,107
Close
149.71quote price arrow up+10.31 (+7.40%)
Volume
12,146,934
52 week range
31.71 - 189.26

...

Loading . . .
  • Open146.80
  • Day High152.11
  • Day Low145.35
  • Prev Close139.40
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low31.71
  • 52 Week Low Date04/13/20

Key Stats

  • Market Cap59.911B
  • Shares Out400.18M
  • 10 Day Average Volume7.67M
  • Dividend-
  • Dividend Yield-
  • Beta1.4
  • YTD % Change43.3

KEY STATS

  • Open146.80
  • Day High152.11
  • Day Low145.35
  • Prev Close139.40
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low31.71
  • 52 Week Low Date04/13/20
  • Market Cap59.911B
  • Shares Out400.18M
  • 10 Day Average Volume7.67M
  • Dividend-
  • Dividend Yield-
  • Beta1.4
  • YTD % Change43.3

RATIOS/PROFITABILITY

  • EPS (TTM)-1.94
  • P/E (TTM)-77.28
  • Fwd P/E (NTM)7.06
  • EBITDA (MRQ)-731.893M
  • ROE (MRQ)-39.99%
  • Revenue (MRQ)803.40M
  • Gross Margin (MRQ)70.05%
  • Net Margin (MRQ)-92.99%
  • Debt To Equity (MRQ)5.24%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO4:2704:27
One top biotech analyst says Moderna is going even higher here

Profile

MORE
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
403.15+4.16+1.04%
BNTX
BioNTech SE
129.64+8.12+6.68%
GMAB
Genmab A/S
34.65+1.07+3.19%
SGEN
Seagen Inc
140.89+0.17+0.12%
EXAS
Exact Sciences Corp
128.00+3.06+2.45%